Lifespan Integration for Posttraumatic Stress Disorder From an Auto Accident
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01263067|
Recruitment Status : Completed
First Posted : December 20, 2010
Last Update Posted : January 14, 2015
|Condition or disease||Intervention/treatment||Phase|
|Posttraumatic Stress Disorder||Behavioral: Lifespan Integration Therapy Behavioral: Lifespan Integration- Control||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||6 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Lifespan Integration Therapy for Posttraumatic Stress Disorder of Adults Involved in an Auto Accident|
|Study Start Date :||October 2010|
|Actual Primary Completion Date :||July 2011|
|Actual Study Completion Date :||January 2012|
|Experimental: Lifespan Integration Therapy (LI)||
Behavioral: Lifespan Integration Therapy
LI treatment guides the client to imaginally visit past memories, and then leads her or him forward through time to the present using a concept referred to as the time line. Beginning with the individual's memories from the traumatic experience, the time line first follows memories from the days and weeks after the trauma, then season by season to the present, and is reviewed in ongoing sessions as increasing details of the traumatic event are uncovered.
|Active Comparator: Waitlist Control- Lifespan Integration||
Behavioral: Lifespan Integration- Control
Participants selected for the control group will be treated 4 weeks following initial contact. Treatment is the same as for the Experimental Group.
- Clinicians Administered PTSD Scale [ Time Frame: following the final treatment session (average of 6 weeks from treatment start date) ]Participants will be assessed with the CAPS following the final treatment session (up to 5 treatment sessions).
- Personality Assessment Inventory [ Time Frame: following the final treatment session (average of 6 weeks from treatment start date) ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01263067
|United States, Washington|
|Argosy University Seattle|
|Seattle, Washington, United States, 98103|
|Study Chair:||Frances Parks, PhD||Argosy University Seattle|